News of Note—FluGen, Roswell Park Cancer Institute and The Vaccine Group

FluGen rounds up more cash, FDA awards a new orphan drug designation and The Vaccine Group forms.

> Madison, Wisconsin-based FluGen reeled in $5.5 million as it prepares for three tests on a universal flu vaccine candidate next year. Xconomy story

> The FDA awarded an orphan drug designation for a glioblastoma vaccine candidate developed at the Roswell Park Cancer Institute. Release

> A spinoff from the University of Plymouth dubbed The Vaccine Group formed to work on vaccines against pathogens such as avian influenza A, Ebola and Marburg viruses, MERS and SARS. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.